WG-303

N/A

Report date: 2025/09/01 16:35:31

Base Information

Drug NameWG-303
Drug Alias NameWG-303WG303
ClassificationCell and gene therapy > Gene therapy > Gene editing
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShen Zhen Wingor Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShen Zhen Wingor Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A